Ars Technica

Europe—not US—first to authorize Moderna’s combo mRNA flu-COVID vaccine

Moderna’s mRNA-based combination vaccine against both flu and COVID-19 has gotten the green light in Europe—but it continues to be shelved in the US, where it was developed. This week, the European ...
Heavy.com

Red Sox Get Major Triston Casas News Amid Losing Streak

The Boston Red Sox are 9-16 through their first 25 games, the deepest under .500 they have been since the 2023 season. An offense that has scored two runs or fewer in ten games this season has been ...
FiercePharma

Sanofi touts tolerability of COVID shot Nuvaxovid in head-to-head trial vs. Moderna's mNexspike

Sanofi’s protein-based vaccine Nuvaxovid has conquered Moderna’s next-generation messenger RNA shot mNexspike in a head-to-head trial assessing the tolerability of the two COVID vaccines. In the phase ...
Sports Illustrated

Triston Casas’ Red Sox Comeback Bid Just Took an Important Turn

The Boston Red Sox don't have one of their best sluggers in the big leagues right now. Triston Casas is still working his way back after his 2025 season was cut short after just 29 games due to a left ...
Robb Report

Knob Creek Just Unveiled a New Limited-Edition Bourbon That’s on the Sweeter Side

If you purchase an independently reviewed product or service through a link on our website, Robb Report may receive an affiliate commission. Could this be an attempt to draw in new drinkers with ...
Heavy.com

Red Sox Get Notable Triston Casas Injury Update

The Boston Red Sox are closing in on Opening Day for the 2026 MLB season. The calendars are set for March 26 in Cincinnati. The roster is taking shape. Triston Casas won’t be taking part. The ...
MarketWatch

Moderna’s stock rallies as settlement of a patent dispute clears vaccine pipeline

Shares of Moderna on Wednesday surged to their highest in more than a year after the pharmaceutical company said it reached a deal to resolve a dispute related to its COVID vaccine. Moderna MRNA said ...
USA Today

Last chance to get 50% off Blenders sunglasses, including Deion Sanders' unique styles

California-based brand, Blenders Eyewear, is celebrating its 14th anniversary with a huge sale. Shoppers can get 50% off stylish and sporty sunglasses for a limited time. The brand is known for its ...
The News Journal

Moderna will pay up to $2.25B to end COVID vaccine patent fight

Moderna MRNA.O has agreed to pay Genevant Sciences, a subsidiary of Roivant Sciences ROIV.O, and Arbutus Biopharma ABUS.O up to $2.25 billion to settle a long-running legal fight over the technology ...
Wall Street Journal

Moderna to Pay $950 Million to Settle Patent Cases From Arbutus, Genevant

Moderna MRNA0.74%increase; green up pointing triangle will pay $950 million to settle patent litigation by Arbutus Biopharma and Genevant Sciences GmbH. The vaccine maker said Tuesday that, as part of ...
STAT

Moderna to pay Roivant up to $2.25 billion to settle patent lawsuit behind mRNA vaccines

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. This story has been updated. Moderna has ...